Search filters

List of works by Brian K Link

18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reports.

scientific article

99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphoma

scientific article published in August 2004

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

scientific article published on 20 February 2018

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

scientific article

A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.

scientific article published on 15 November 2011

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

scientific journal article

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

scientific article

A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemia

scientific article published on 01 April 1989

A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma

scientific article

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

scientific article published on 17 April 2018

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.

scientific article published on 9 September 2016

A systematic review of validated methods for identifying lymphoma using administrative data

scientific article

Abstract 5071: A genome-wide association study suggests evidence of variants at 6p21.32 associated with marginal zone lymphoma

Abstract 5072: Meta-analysis of genome-wide association studies identifies novel susceptibility loci for follicular lymphoma

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma

scientific article

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

scientific article published on 30 August 2019

Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

journal article published in 2015

Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab.

scientific article published on 6 July 2006

Antibody therapy of lymphoma

scientific article published on 01 January 2004

Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma

scientific article published on 6 April 2017

Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

article

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: a NLCS and CIBMTR Analysis.

scientific article published on 11 December 2017

Biosimilars: when a negative study can be positive

scientific article published on 01 November 2018

CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia

scientific article published on 01 May 2001

CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis ⬇️

scientific article published on June 28, 2013

Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts

scientific article published on 27 November 2018

Chemo-immunotherapy dosing in older patients with diffuse large B-cell lymphoma: is this how we should treat our parents? ⬇️

scientific article published on 02 April 2012

Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL c

scientific article

Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin's lymphoma.

scientific article published on March 2011

Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy.

scientific article published on 27 June 2017

Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.

scientific article published on 18 August 2017

Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes

scientific article published on October 2012

Comparative effectiveness research in follicular lymphoma: current and future perspectives and challenges

scientific article published on January 2014

Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States

scientific article published on 05 November 2014

Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy.

scientific article published on 15 August 2016

Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101

scientific article

Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.

scientific article

Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of care.

scientific article published in September 2001

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

scientific article published on 19 April 2018

Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines

scientific article published on 21 February 2011

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

scientific article

Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.

scientific article published on 11 September 2015

Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.

scientific article published on 07 April 2015

Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States

scientific article

Disseminated CD8-positive, CD30-positive cutaneous lymphoproliferative eruption with overlapping features of mycosis fungoides and primary cutaneous anaplastic large cell lymphoma following remote solitary lesional presentation.

scientific article published on 12 May 2017

Early Relapse in Follicular Lymphoma: High Risks and High Stakes.

scientific article published in December 2017

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

scientific article published on 27 July 2016

Effect of Clinical Characteristics on Neutropenia-Related Inpatient Costs Among Newly Diagnosed Non-Hodgkin's Lymphoma Cases During First-Course Chemotherapy

scientific article published on 01 May 2005

Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.

scientific article published on 20 August 2012

Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma ⬇️

scientific article published on March 7, 2011

Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma

scientific article

Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.

scientific article

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.

scientific article published on 17 October 2011

Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.

scientific article

Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma.

scientific article published on 10 February 2014

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

scientific article

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.

scientific article published on 18 February 2014

Event-free survival at 24 months captures central nervous system relapse of systemic diffuse large B-cell lymphoma in the immunochemotherapy era.

scientific article published on 29 September 2017

Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.

scientific article published on 5 October 2012

FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein-Barr virus status.

scientific article published on 3 June 2013

FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts

scientific article published on 10 June 2016

Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate-grade non-Hodgkin's lymphoma

scientific article published in September 2003

Follicular lymphoma following liver transplantation: report of a unique case with review of the literature.

scientific article

Follicular lymphomatoid papulosis with follicular mucinosis: a clinicopathologic study of 3 cases with literature review and conceptual reappraisal

scientific article published on 23 December 2016

Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated with Dose-Adjusted EPOCH plus Rituximab.

scientific article published on 18 July 2017

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

scientific article published on 13 August 2019

Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma

scientific article

Genetically Determined Height and Risk of Non-hodgkin Lymphoma

scientific article published on 01 January 2019

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

scientific article

Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

scientific article published on 12 October 2015

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

scientific article published on 06 February 2017

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

scientific journal article

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region

scientific article published in October 2014

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

scientific journal article

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

scientific article

Germline variation in complement genes and event‐free survival in follicular and diffuse large B‐cell lymphoma ⬇️

scientific article published on June 20, 2012

HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.

scientific article

Health-related quality of life in patients with cutaneous T-cell lymphoma?

scientific article published on 03 August 2018

History of autoimmune conditions and lymphoma prognosis

scientific article published on 01 August 2018

Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study

scientific article published on 15 March 2019

Human Pegivirus infection and lymphoma risk and prognosis: a North American study

scientific article published on 29 May 2018

Humanization and characterization of the anti-HLA-DR antibody 1D10.

scientific article published in August 2001

Identification of candidate B-lymphoma genes by cross-species gene expression profiling

scientific article

Imaging guiding therapy development in lymphoma.

scientific article published on October 2008

Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.

scientific article published on 6 December 2004

Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma

scientific article published on 01 October 2019

Improved survival of follicular lymphoma patients in the United States

scientific article published on 27 June 2005

Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation.

scientific article

Influences on oncologists' adoption of new agents in adjuvant chemotherapy of breast cancer

scientific article published on 01 February 2001

Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.

scientific article published on 13 June 2016

Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy

scientific article

Isolated unilateral facial nerve palsy: an unusual manifestation of recurrent diffuse large B-cell lymphoma

scientific article published on 09 March 2015

Long-term follow up of rates of secondary malignancy and late relapse of two trials using radioimmunotherapy consolidation following induction chemotherapy for previously untreated indolent lymphoma.

scientific article published on 13 February 2015

Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.

scientific article published in November 2005

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

scientific article

Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma

scientific article published on 21 December 2018

Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes

scientific article published on 10 January 2013

Measuring granulocyte and monocyte accumulation at malignant lymphoma sites

scientific article published on 24 November 2008

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

scientific article published on 9 March 2016

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with rearrangements

scientific article published on 09 August 2018

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

article

Monoclonal antibodies in the treatment of human B-cell malignancies.

scientific article published in October 1998

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas ⬇️

scientific article published on November 3, 2011

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma

scientific article

Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy.

scientific article

Novel treatment approaches and future perspectives in follicular lymphoma

scientific article published on 11 January 2019

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.

scientific article

Optic neuropathy due to anaplastic large cell lymphoma

scientific article published on 01 September 2004

Outcomes among US patients with diffuse large B cell lymphoma are independent of tumor Epstein Barr virus positivity or immunosuppression

scientific article published on 23 November 2017

Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.

scientific article published on 5 January 2016

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

scientific article published on 03 August 2017

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)

scientific article

Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal.

scientific article published on 08 May 2013

Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.

scientific article published on 4 September 2013

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma

scientific article published on 22 October 2015

Phase 1/2 study of ocaratuzumab, an Fc-engineered humanized anti-CD20 monoclonal antibody, in low-affinity FcγRIIIa patients with previously treated follicular lymphoma.

scientific article published on 14 July 2014

Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.

scientific article

Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia

scientific article

Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results.

scientific article

Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma.

scientific article

Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma

scientific article published on 01 October 2007

Phase II Trial of Remitogen™ (Humanized 1D10) Monoclonal Antibody Targeting Class II in Patients with Relapsed Low-Grade or Follicular Lymphoma

scientific article published on 01 December 2001

Population-based Assessment of Hospitalizations for Neutropenia from Chemotherapy in Older Adults with Non-Hodgkin’s Lymphoma (United States)

scientific article published on 01 June 2006

Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy

scientific article published on 14 November 2019

Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study

scientific article

Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma

scientific article published on 05 December 2018

Primary diffuse large B cell lymphoma of the vulva-Two new cases of a rare entity and review of the literature

scientific article published on 16 October 2018

Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma

scientific article published on 18 October 2013

Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

article

Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma

scientific article published on 03 June 2018

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource ⬇️

scientific article published on July 29, 2013

Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: A series of 10 adult and pediatric patients and review of the literature ⬇️

scientific article published on 08 June 2011

Recommendations for Clinical Trial Development in Follicular Lymphoma

scientific article published on 31 December 2016

Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma

scientific article published on 17 May 2019

Relationships between chemotherapy, chemotherapy dose intensity and outcomes of follicular lymphoma in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence Molecular Epidemi

scientific article

Reply to V. Pitini et al and L.J. Costa

scientific article published on 23 March 2015

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography

scientific article

Results of a phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcγRIIIa-genotyped patients with previously treated follicular lymphoma

scientific article published on 05 January 2012

Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment

scientific article published on 01 September 2000

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

scientific article

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism.

scientific article

Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity

scientific article published on 01 December 1999

Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study.

scientific article published on 2 April 2018

Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients.

scientific article published on 30 December 2016

Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma

scientific article published on 13 October 2017

Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL

scientific article published on 05 March 2020

The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma

scientific article published on 6 September 2012

The association of physical activity before and after lymphoma diagnosis with survival outcomes

scientific article published on 17 October 2018

The mysteries of mantle cell lymphoma--do PET scans provide a clue?

scientific article published on 01 September 2008

The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma

scientific article published on April 2015

The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.

scientific article

The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas

scientific article published on 10 April 2019

Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

scientific article published on 19 July 2017

Transformation of follicular lymphoma - Why does it happen and can it be prevented?

scientific article published in November 2017

Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma

scientific article published in April 2015

Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile

scientific article

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.

scientific article published on 21 February 2018

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

scientific article published in Nature Communications

Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length.

scientific article

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

scientific article

Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia.

scientific article

Variability of performance status assessment between patients with hematologic malignancies and their physicians.

scientific article

Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.

scientific article

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma.

scientific article

Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma.

scientific article

Will a Better Understanding of the Problem With Transformed Follicular Lymphoma Lead to Better Outcomes?

scientific article published on 13 June 2016

Paulina is supported by:

About Paulina

Help